Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals plc | 3,931,818 | 3,931,818 | 0 | $44.43M | $35.50M | 38.83% | -$8.93M |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | $112.37M | $33.93M | 37.11% | -$78.44M |
| Dyne Therapeutics, Inc.(DYN) | 407,499 | 407,499 | 0 | $11.57M | $14.38M | 15.73% | +$2.81M |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | $8.04M | $4.19M | 4.58% | -$3.85M |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | $3.59M | $3.43M | 3.75% | -$165.9K |